Brand Asset Management Group’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Sell
5,996
-206
-3% -$19.4K 0.14% 109
2026
Q1
$488K Sell
6,202
-169
-3% -$13.6K 0.13% 103
2025
Q4
$463K Sell
6,371
-113
-2% -$8.02K 0.13% 95
2025
Q3
$438K Buy
+6,484
New +$419K 0.12% 95
2022
Q3
Sell
-4,840
Closed -$231K 76
2022
Q2
$231K Buy
4,840
+4
+0.1% +$213 0.12% 71
2022
Q1
$281K Buy
4,836
+1
+0% +$59 0.12% 70
2021
Q4
$293K Buy
4,835
+978
+25% +$59.5K 0.13% 64
2021
Q3
$234K Hold
3,857
0.11% 71
2021
Q2
$241K Hold
3,857
0.12% 68
2021
Q1
$229K Buy
3,857
+3,000
+350% +$178K 0.12% 67
2020
Q4
$49K Buy
857
+40
+5% +$2.05K 0.03% 124
2020
Q3
$38K Buy
817
+54
+7% +$2.5K 0.02% 138
2020
Q2
$33K Buy
+763
New +$30.5K 0.02% 145

Other funds holding EMXC

Brand Asset Management Group's EMXC Position: Q2 2026 in Review

Brand Asset Management Group reduced its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 3.3% in Q2 2026, selling an estimated $19.4K and leaving 5,996 shares worth $613K. The position accounts for 0.14% of the portfolio, ranked #109.

Brand Asset Management Group first reported a position in EMXC in Q2 2020 and has held it in 13 quarters since. 1,014 funds tracked by Wall St. Rank hold EMXC as of Q2 2026.

  • Brand Asset Management Group held 5,996 shares of iShares MSCI Emerging Markets ex China ETF worth $613K as of Q2 2026.
  • Brand Asset Management Group sold 206 iShares MSCI Emerging Markets ex China ETF shares in Q2 2026, an estimated $19.4K.
  • iShares MSCI Emerging Markets ex China ETF made up 0.14% of Brand Asset Management Group's portfolio in Q2 2026, its #109 holding.
  • Brand Asset Management Group first reported a position in iShares MSCI Emerging Markets ex China ETF in Q2 2020 and has held it in 13 quarters since.
  • 1,014 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q2 2026.

Based on Brand Asset Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.